Stock Details
BMY is Bristol-Myers Squibb Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 76.17$. Average daily volumn in 3 months 14.73M. Market cap 163.60B



Stock symbol : BMY. Exchange : NYSE. Currency : USD
Lastest price : 76.84$. Total volume : 10.88M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Bristol-Myers Squibb Company (BMY)
Last Price
76.84$
Change
-0.16
Volume
10.88M

Previous Close77.00
Open76.98
Day Range75.77-76.98
Bid75.50 x 800
Ask79.00 x 900
Volume10.88M
Average Volume14.73M
Market Cap163.6B
Beta0.48
52 Week Range53.22-80.59
Trailing P/E27.25
Foward P/E9.50
Dividend (Yield %)2.81%
Ex-Dividend Date2022-06-30



Financial Details


According to Bristol-Myers Squibb Company's financial reports the company's revenue in 2021 were 46.38B an increase( +9.52%) over the years 2020 revenue that were of 42.52B. In 2021 the company's total earnings were 6.99B while total earnings in 2020 were -9.02B(-166.67%).


Loading ...



Organization

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indi... cations; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

Market Cap:
163.60B
Revenue:
46.38B
Total Assets:
109.31B
Total Cash:
13.98B


News about "Bristol-Myers Squibb Company"

carillon-tower-bristol-myers-squibb-bmy-entered-into-accelerated-share-repurchase-agreements-image

Carillon Tower: โ€œBristol-Myers Squibb (BMY) Entered Into Accelerated Share Repurchase Agreementsโ€

Source from : Yahoo! Sports - 1 days ago

Carillon Tower Advisers, an investment management firm, published its โ€œCarillon Clarivest Capital Appreciation Fundโ€ first quarter 2022 investor letter โ€“ a copy of which can be downloaded here. At the ...See details»


bristol-myers-squibb-when-will-the-correction-end-image

Bristol-Myers Squibb: When Will The Correction End?

Source from : Seeking Alpha - 5 days ago

Bristol-Myers Squibb's EBITDA margin is 47.2% at the end of Q1, one of the largest in the pharmaceutical industry. Find out when the correction might end.See details»


bristol-myers-squibb-company-nysebmy-stock-goes-ex-dividend-in-just-two-days-image

Bristol-Myers Squibb Company (NYSE:BMY) Stock Goes Ex-Dividend In Just Two Days

Source from : YAHOO!Finance - 7 days ago

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Bristol-Myers Squibb Company (NYSE:BMY) is about to trade ex-dividend in the next two days.See details»


bristol-myers-squibb-nysebmy-shares-purchased-by-great-valley-advisor-group-inc-image

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Great Valley Advisor Group Inc.

Source from : Defense World - 2 days ago

Great Valley Advisor Group Inc. grew its position in shares of Bristol-Myers Squibb (NYSE:BMY โ€“ Get Rating) by 7.5% during the first quarter, according to its most recent Form 13F filing with the ...See details»


bristol-myers-squibb-nysebmy-shares-sold-by-creative-financial-designs-inc-adv-image

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Creative Financial Designs Inc. ADV

Source from : Defense World - 5 days ago

Creative Financial Designs Inc. ADV trimmed its holdings in shares of Bristol-Myers Squibb (NYSE:BMY โ€“ Get Rating) by 90.6% in the first quarter, according to its most recent 13F filing with the ...See details»


bristol-myers-squibb-annual-mid-single-digit-growth-equals-incremental-upside-image

Bristol-Myers Squibb: Annual Mid Single-Digit Growth Equals Incremental Upside

Source from : Seeking Alpha - 6 days ago

BMY shares were stagnant for nearly 5 years before gaining ~30% across the past 6 months. Read more to find out why BMY shares remain good value.See details»


Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know

Source from : YAHOO!Finance - 5 days ago

Bristol Myers Squibb (BMY) closed the most recent trading day at $78.28, moving -0.53% from the previous trading session.See details»


Looking Into Bristol-Myers Squibb's Recent Short Interest

Source from : Benzinga.com - 5 days ago

Bristol-Myers Squibb's (NYSE:BMY) short percent of float has risen 4.49% since its last report. The company recently reported that it has 34.46 million shares sold short, which is 1.63% of all regular ...See details»


Bristol-Myers Squibb Company (NYSE:BMY) Slides -0.22 Percent In Recent Trade, What Can We Expect Next?

Source from : stocksregister - 5 days ago

Bristol-Myers Squibb Company (NYSE:BMY) traded at $78.53 at last check on Wednesday, June 29, made a downward move of -0.22% on its previous dayโ€™s price. Looking at the stock we see that its previous ...See details»


heres-how-to-treat-bristol-myers-squibbs-charts-image

Here's How to Treat Bristol-Myers Squibb's Charts

Source from : TheStreet.com - 7 days ago

Pharmaceutical giant Bristol-Myers Squibb (BMY) has broken out to a new high for the move up. Traders should be long from our March 7 review, where we wrote that "Traders could go long BMY at current ...See details»


Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company

Source from : MarketWatch - 1 month ago

Bristol Myers Squibb expects to finance the acquisition with cash on hand. Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of investigational drugs ...See details»


bristol-myers-must-face-64-bln-lawsuit-over-delayed-cancer-drug-image

Bristol Myers must face $6.4 bln lawsuit over delayed cancer drug

Source from : Reuters - 10 days ago

A U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co of delaying its Breyanzi cancer drug to avoid payments to shareholders of the former Celgene Corp, ...See details»


hya-advisors-inc-takes-position-in-bristol-myers-squibb-nysebmy-image

HYA Advisors Inc Takes Position in Bristol-Myers Squibb (NYSE:BMY)

Source from : ETF Daily News - 12 days ago

HYA Advisors Inc purchased a new stake in Bristol-Myers Squibb (NYSE:BMY โ€“ Get Rating) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased ...See details»


ex-dividend-reminder-choice-hotels-international-sysco-and-bristol-myers-squibb-image

Ex-Dividend Reminder: Choice Hotels International, Sysco and Bristol Myers Squibb

Source from : Nasdaq - 6 days ago

Looking at the universe of stocks we cover at Dividend Channel, on 6/30/22, Choice Hotels International, Inc. (Symbol: CHH), Sysco Corp (Symbol: SYY), and Bristol Myers Squibb Co. (Symbol: BMY) will ...See details»